Published in J Biol Chem on June 10, 1994
Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat Rev Microbiol (2008) 3.25
Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol (2008) 2.97
Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes. Protein Sci (1998) 2.52
Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency. J Virol (2000) 2.33
PAI-1 in tissue fibrosis. J Cell Physiol (2012) 2.26
Stage- and gender-specific proteomic analysis of Brugia malayi excretory-secretory products. PLoS Negl Trop Dis (2008) 2.06
Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev (2010) 1.97
Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J (1995) 1.73
Anopheles gambiae SRPN2 facilitates midgut invasion by the malaria parasite Plasmodium berghei. EMBO Rep (2005) 1.70
Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ (1997) 1.66
Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease. J Virol (1996) 1.62
Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest (1999) 1.60
Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol (1998) 1.59
Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci (2000) 1.58
Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology (2002) 1.56
The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J Exp Med (2000) 1.50
A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci U S A (1995) 1.47
Predicting conformational switches in proteins. Protein Sci (1999) 1.38
Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol (2005) 1.36
alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor. J Cell Biol (1995) 1.35
Genes identified by an expression screen of the vector mosquito Anopheles gambiae display differential molecular immune response to malaria parasites and bacteria. Proc Natl Acad Sci U S A (2000) 1.33
Granzyme A activates another way to die. Immunol Rev (2010) 1.28
Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization. J Exp Med (2005) 1.27
EPO receptor circuits for primary erythroblast survival. Blood (2008) 1.26
Identification of plasma proteases inhibited by Manduca sexta serpin-4 and serpin-5 and their association with components of the prophenol oxidase activation pathway. J Biol Chem (2005) 1.25
A tick salivary protein targets cathepsin G and chymase and inhibits host inflammation and platelet aggregation. Blood (2010) 1.20
Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br J Cancer (2000) 1.20
The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease. Infect Immun (1999) 1.20
The necrotic gene in Drosophila corresponds to one of a cluster of three serpin transcripts mapping at 43A1.2. Genetics (2000) 1.19
Nucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1. Mol Cell Biol (2001) 1.18
Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology. Thorax (2004) 1.18
Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax (1998) 1.17
Familial encephalopathy with neuroserpin inclusion bodies. Am J Pathol (1999) 1.16
Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo. J Exp Med (1999) 1.16
Update of the human and mouse SERPIN gene superfamily. Hum Genomics (2013) 1.12
Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem J (1999) 1.08
Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7. J Exp Med (2004) 1.08
Industrial melanism in the peppered moth is not associated with genetic variation in canonical melanisation gene candidates. PLoS One (2010) 1.07
A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy. J Clin Invest (1998) 1.01
Prolastin, a pharmaceutical preparation of purified human alpha1-antitrypsin, blocks endotoxin-mediated cytokine release. Respir Res (2005) 1.01
Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination. J Biomed Biotechnol (2012) 1.01
New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy. Dermatology (2009) 1.00
Alpha-1-antitrypsin deficiency: current concepts. Lung (2007) 1.00
The Kunitz-like modulatory protein haemangin is vital for hard tick blood-feeding success. PLoS Pathog (2009) 0.99
Reactivities of the S2 and S3 subsite residues of thrombin with the native and heparin-induced conformers of antithrombin. Protein Sci (1998) 0.99
Two non-homologous brain diseases-related genes, SERPINI1 and PDCD10, are tightly linked by an asymmetric bidirectional promoter in an evolutionarily conserved manner. BMC Mol Biol (2007) 0.98
Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs). Biochimie (2010) 0.97
Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice. Am J Pathol (2000) 0.97
The HNF-4/HNF-1alpha transactivation cascade regulates gene activity and chromatin structure of the human serine protease inhibitor gene cluster at 14q32.1. Proc Natl Acad Sci U S A (1999) 0.95
Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem J (1996) 0.95
Stimulatory effect of inflammatory cytokines on alpha 1-antichymotrypsin expression in human lung-derived epithelial cells. J Clin Invest (1995) 0.94
Manduca sexta serpin-5 regulates prophenoloxidase activation and the Toll signaling pathway by inhibiting hemolymph proteinase HP6. Insect Biochem Mol Biol (2010) 0.94
A serine protease inhibitor, protease nexin I, rescues motoneurons from naturally occurring and axotomy-induced cell death. Proc Natl Acad Sci U S A (1995) 0.93
Inter-α-inhibitor blocks epithelial sodium channel activation and decreases nasal potential differences in ΔF508 mice. Am J Respir Cell Mol Biol (2014) 0.92
Emergence and evolution of the renin-angiotensin-aldosterone system. J Mol Med (Berl) (2012) 0.91
Proprotein convertase PC7 enhances the activation of the EGF receptor pathway through processing of the EGF precursor. J Biol Chem (2011) 0.91
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. Thorax (1999) 0.90
Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease. Blood (2006) 0.90
Serpin-1 splicing isoform J inhibits the proSpätzle-activating proteinase HP8 to regulate expression of antimicrobial hemolymph proteins in Manduca sexta. Dev Comp Immunol (2010) 0.89
Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer. Br J Cancer (2005) 0.89
Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis. J Korean Med Sci (2005) 0.88
Systematic identification and integrative analysis of novel genes expressed specifically or predominantly in mouse epididymis. BMC Genomics (2006) 0.88
Molecular cloning and characterization of a novel serpin gene of Clonorchis sinensis, highly expressed in the stage of metacercaria. Parasitol Res (2009) 0.87
SPI-1-dependent host range of rabbitpox virus and complex formation with cathepsin G is associated with serpin motifs. J Virol (1999) 0.87
Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet J Rare Dis (2011) 0.87
Effect of protease-activated receptor (PAR)-1, -2 and -4-activating peptides, thrombin and trypsin in rat isolated airways. Br J Pharmacol (2000) 0.87
Identification of fibrin clot-bound plasma proteins. PLoS One (2012) 0.86
HuD binds to three AU-rich sequences in the 3'-UTR of neuroserpin mRNA and promotes the accumulation of neuroserpin mRNA and protein. Nucleic Acids Res (2002) 0.86
Clinicopathological significance of maspin expression in breast cancer. J Korean Med Sci (2006) 0.86
Differential regulation of gene activity and chromatin structure within the human serpin gene cluster at 14q32.1 in macrophage microcell hybrids. Nucleic Acids Res (2000) 0.86
Oncostatin M, leukaemia-inhibitory factor and interleukin 6 trigger different effects on alpha1-proteinase inhibitor synthesis in human lung-derived epithelial cells. Biochem J (1998) 0.85
Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells. Biochem J (1995) 0.84
Engineering kunitz domain 1 (KD1) of human tissue factor pathway inhibitor-2 to selectively inhibit fibrinolysis: properties of KD1-L17R variant. J Biol Chem (2010) 0.84
Serpin Inhibition Mechanism: A Delicate Balance between Native Metastable State and Polymerization. J Amino Acids (2011) 0.83
Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells. J Virol (1999) 0.83
Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review. CNS Neurosci Ther (2009) 0.83
Loop variants of the serpin thyroxine-binding globulin: implications for hormone release upon limited proteolysis. Biochem J (2002) 0.83
Global gene expression profiling in PAI-1 knockout murine heart and kidney: molecular basis of cardiac-selective fibrosis. PLoS One (2013) 0.82
Identification and analysis of serpin-family genes by homology and synteny across the 12 sequenced Drosophilid genomes. BMC Genomics (2009) 0.82
The plasminogen activator system modulates sympathetic nerve function. J Exp Med (2006) 0.82
Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency. Biologics (2009) 0.82
Prognostic significance of maspin in pancreatic ductal adenocarcinoma. Korean J Intern Med (2004) 0.82
Enzymatic activation of endothelial protease-activated receptors is dependent on artery diameter in human and porcine isolated coronary arteries. Br J Pharmacol (2002) 0.81
An original SERPINA3 gene cluster: elucidation of genomic organization and gene expression in the Bos taurus 21q24 region. BMC Genomics (2008) 0.81
Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis. PLoS One (2011) 0.81
Molecular linkage of the human alpha 1-antitrypsin and corticosteroid-binding globulin genes on chromosome 14q32.1. Mamm Genome (1997) 0.81
Local and global effects of a cavity filling mutation in a metastable serpin. Biochemistry (2009) 0.81
Decreased expression of SERPINB1 correlates with tumor invasion and poor prognosis in hepatocellular carcinoma. J Mol Histol (2013) 0.80
Regulation of the human plasminogen activator inhibitor type 2 gene: cooperation of an upstream silencer and transactivator. J Biol Chem (2012) 0.80
Pepsin-inhibitory activity of the uterine serpins. Proc Natl Acad Sci U S A (1996) 0.80
RNAi-mediated knockdown of serine protease inhibitor genes increases the mortality of Plutella xylostella challenged by destruxin A. PLoS One (2014) 0.79
Structural factors affecting the choice between latency transition and polymerization in inhibitory serpins. Protein Sci (2007) 0.79
Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia. PLoS One (2012) 0.79
Helicobacter pylori-mediated gastritis induces local downregulation of secretory leukocyte protease inhibitor in the antrum. Infect Immun (2004) 0.79
The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin. Protein Sci (2001) 0.78
Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group. ACS Med Chem Lett (2012) 0.78
Transgenic overexpression of a stable Plasminogen Activator Inhibitor-1 variant. Thromb Res (2008) 0.78
Crystallization and preliminary X-ray diffraction analysis of a protease inhibitor from the haemolymph of the Indian tasar silkworm Antheraea mylitta. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.78
Stable expression and cell-specific chromatin structure of human alpha1-antitrypsin cosmid transgenes in rat hepatoma cells. Nucleic Acids Res (2000) 0.78
Human plasma proteinase inhibitors. Annu Rev Biochem (1983) 6.61
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81
Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry (1976) 3.57
Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem (1980) 3.14
Lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Isolation, characterization, and evidence for the existence of complexes with hemagglutinins. J Biol Chem (1994) 2.90
Selective removal of albumin from plasma by affinity chromatography. Clin Chim Acta (1973) 2.69
Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci U S A (1997) 2.63
The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. J Biol Chem (1979) 2.57
Primary structure of human neutrophil elastase. Proc Natl Acad Sci U S A (1987) 2.45
Isolation and properties of human plasma alpha-1-proteinase inhibitor. Biochemistry (1974) 2.40
Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 (2000) 2.29
Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Biochemistry (1987) 2.24
Signal-specific co-activator domain requirements for Pit-1 activation. Nature (1998) 2.22
Isolation of albumin from whole human plasma and fractionation of albumin-depleted plasma. Biochem J (1976) 2.15
The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect Immun (1995) 2.03
Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun (1979) 2.00
Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem (1992) 1.99
Molecular cloning and structural characterization of the Arg-gingipain proteinase of Porphyromonas gingivalis. Biosynthesis as a proteinase-adhesin polyprotein. J Biol Chem (1995) 1.98
Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem (1992) 1.96
Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun (1999) 1.96
Why Eric Mazur Brings Chaos--Not Chaos Theory--to Physics. Science (1994) 1.87
Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor. J Biol Chem (1978) 1.79
Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J (1999) 1.79
Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood (2001) 1.77
X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J (1986) 1.76
Isolation and properties of human neutrophil myeloperoxidase. Biochemistry (1981) 1.71
Characterization of the binding activities of proteinase-adhesin complexes from Porphyromonas gingivalis. J Bacteriol (1996) 1.69
Comparative properties of two cysteine proteinases (gingipains R), the products of two related but individual genes of Porphyromonas gingivalis. J Biol Chem (1998) 1.68
Reviving the antibiotic miracle? Science (1994) 1.67
Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest (1994) 1.56
Isolation and properties of oxidized alpha-1-proteinase inhibitor from human rheumatoid synovial fluid. Biochem Biophys Res Commun (1980) 1.56
Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem (1982) 1.51
Titration and mapping of the active site of cysteine proteinases from Porphyromonas gingivalis (gingipains) using peptidyl chloromethanes. Biol Chem (1997) 1.48
Scoring a technical knockout in mice. Science (1992) 1.45
Purification of human alpha-2-macroglobulin by chromatography on Cibacron Blue Sepharose. Anal Biochem (1978) 1.44
Inactivation of tumor necrosis factor-alpha by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion. J Biol Chem (1998) 1.43
Molecular cloning and characterization of Porphyromonas gingivalis lysine-specific gingipain. A new member of an emerging family of pathogenic bacterial cysteine proteinases. J Biol Chem (1997) 1.43
The degradation of human lung elastin by neutrophil proteinases. Biochim Biophys Acta (1980) 1.40
Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett (1988) 1.39
Role of gingipains R in the pathogenesis of Porphyromonas gingivalis-mediated periodontal disease. Clin Infect Dis (1999) 1.39
Identification of the primary antimicrobial domains in human neutrophil cathepsin G. J Biol Chem (1990) 1.38
Porphyromonas gingivalis: a proteinase/gene accounting audit. Trends Microbiol (1995) 1.38
Army targets a potential vaccine against cholesterol. Science (1993) 1.38
The degradation of human glomerular basement membrane with purified lysosomal proteinases: evidence for the pathogenic role of the polymorphonuclear leucocyte in glomerulonephritis. Clin Sci Mol Med (1978) 1.38
Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun (2001) 1.35
Modulation of interleukin-8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease. FEBS Lett (1998) 1.33
Structural and functional characterization of the abnormal Z alpha 1-antitrypsin isolated from human liver. FEBS Lett (1984) 1.24
Primary structure of the reactive site of human C1-inhibitor. J Biol Chem (1985) 1.23
Human alpha-1-antichymotrypsin: interaction with chymotrypsin-like proteinases. Biochemistry (1978) 1.21
Molecular uniformity in biological catalyses. The enzymes concerned with firefly luciferin, amino acid, and fatty acid utilization are compared. Science (1967) 1.19
Genetic and environmental variation in the visual properties of bluefin killifish, Lucania goodei. J Evol Biol (2005) 1.17
The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities. EMBO J (1996) 1.17
Inactivation of human alpha 1-proteinase inhibitor by thiol proteinases. Biochem J (1977) 1.17
Dependence of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis. Infect Immun (1995) 1.17
Cleavage and activation of proteinase-activated receptor-2 on human neutrophils by gingipain-R from Porphyromonas gingivalis. FEBS Lett (1998) 1.16
Interaction of human alpha-1-proteinase inhibitor with neutrophil myeloperoxidase. Biochemistry (1981) 1.16
Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect Immun (1996) 1.15
Degradation of host heme proteins by lysine- and arginine-specific cysteine proteinases (gingipains) of Porphyromonas gingivalis. J Bacteriol (2001) 1.14
Population variation in opsin expression in the bluefin killifish, Lucania goodei: a real-time PCR study. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2003) 1.14
A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect Immun (1998) 1.14
Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Biochem Biophys Res Commun (1999) 1.13
Human leucocyte elastase and cathepsin G: structural and functional characteristics. Ciba Found Symp (1979) 1.13
The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem (1997) 1.13
Effect of free and vesicle-bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implications for bleeding tendency at periodontitis sites. Infect Immun (1995) 1.13
Factor-specific modulation of CREB-binding protein acetyltransferase activity. Proc Natl Acad Sci U S A (1999) 1.12
Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide. J Biol Chem (1991) 1.12
Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes. J Biol Chem (1998) 1.12
Genetic variation of Porphyromonas gingivalis genes encoding gingipains, cysteine proteinases with arginine or lysine specificity. Biol Chem (1998) 1.10
Prolyl tripeptidyl peptidase from Porphyromonas gingivalis. A novel enzyme with possible pathological implications for the development of periodontitis. J Biol Chem (1999) 1.09
Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells. J Biol Chem (1997) 1.09
Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells. Cell Microbiol (2008) 1.08
Degradation of elastin by a cysteine proteinase from Staphylococcus aureus. J Biol Chem (1988) 1.08
Two allelic forms of the aureolysin gene (aur) within Staphylococcus aureus. Infect Immun (2000) 1.08
Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J Biol Chem (1997) 1.07
Human pancreatic enzymes: purification and characterization of a nonelastolytic enzyme, protease E. resembling elastase. Biochemistry (1975) 1.06
Human alpha-1-antichymotrypsin: purification and properties. Biochemistry (1978) 1.06
A new insight into phagocytosis of apoptotic cells: proteolytic enzymes divert the recognition and clearance of polymorphonuclear leukocytes by macrophages. Cell Death Differ (2006) 1.05
pH-regulated secretion of a glyceraldehyde-3-phosphate dehydrogenase from Streptococcus gordonii FSS2: purification, characterization, and cloning of the gene encoding this enzyme. J Dent Res (2001) 1.04
Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 A resolution. J Mol Biol (1992) 1.04
Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res (1995) 1.04
Amino-acid sequence and three-dimensional structure of the Staphylococcus aureus metalloproteinase at 1.72 A resolution. Structure (1998) 1.04
Multiple paternity and population genetic structure in natural populations of the poeciliid fish, Heterandria formosa. J Evol Biol (2003) 1.04
The inactivation of human plasma alpha 1-proteinase inhibitor by proteinases from Staphylococcus aureus. J Biol Chem (1986) 1.04
The amino terminal amino acid sequence of human angiotensinogen. Biochem Biophys Res Commun (1981) 1.03
Porphyromonas gingivalis proteinases in periodontitis, a review. Acta Biochim Pol (1996) 1.03
Isolation and properties of recombinant DNA produced variants of human alpha 1-proteinase inhibitor. J Biol Chem (1985) 1.03
Human leukocyte cathepsin G. Subsite mapping with 4-nitroanilides, chemical modification, and effect of possible cofactors. Biochemistry (1985) 1.02
Purification and characterization of a novel cysteine proteinase (periodontain) from Porphyromonas gingivalis. Evidence for a role in the inactivation of human alpha1-proteinase inhibitor. J Biol Chem (1999) 1.02
Heparin-dependent modification of the reactive center arginine of antithrombin and consequent increase in heparin binding affinity. J Biol Chem (1997) 1.00
Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites. Science (1988) 0.99
Clonal chromosomal abnormalities in osteofibrous dysplasia. Implications for histopathogenesis and its relationship with adamantinoma. Cancer (1994) 0.99
A genetically engineered mutant of alpha 1-antitrypsin protects connective tissue from neutrophil damage and may be useful in lung disease. Lancet (1984) 0.98
Intraspecific variation in retinal cone distribution in the bluefin killifish, Lucania goodei. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2003) 0.98
Human alpha-1-proteinase inhibitor mechanism of action: evidence for activation by limited proteolysis. Biochem Biophys Res Commun (1976) 0.98
Proteolysis of ICAM-1 on human oral epithelial cells by gingipains. J Dent Res (2003) 0.97
Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Lab Invest (1996) 0.97
Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency. J Clin Invest (1988) 0.97
Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV. Infect Immun (2000) 0.97
Proteolytic inactivation of alpha-1-anti-chymotrypsin. Sites of cleavage and generation of chemotactic activity. J Biol Chem (1991) 0.97